LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
40 hedge funds and large institutions have $85.7M invested in LYRA THERAPEUTICS INC in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 8 closing their positions.
7% more capital invested
Capital invested by funds: $79.8M → $85.7M (+$5.93M)
0.1% more ownership
Funds ownership: 1.09% → 1.18% (+0.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 43 → 40 (-3)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$7.31M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.82M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.46M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$622K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$543K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.15M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$947K |
| 4 |
Millennium Management
New York
|
-$566K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$542K |
LYRA Hedge Fund Activity: Q3 2020 in Review
40 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q3 2020, worth a combined $85.7M — up 7.4% from $79.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LYRA and 5 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 12 added.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $7.31M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.9M sold.
- 40 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q3 2020, down from 43 in Q2 2020.
- Funds reported $85.7M of LYRA THERAPEUTICS INC stock for Q3 2020, up 7.4% quarter-over-quarter.
- 5 funds opened new LYRA THERAPEUTICS INC positions in Q3 2020 and 8 closed out, a net change of -3 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q3 2020 was ArrowMark Colorado Holdings, an estimated $7.31M added.
- The largest LYRA THERAPEUTICS INC seller in Q3 2020 was Citadel Advisors, an estimated $2.9M sold.
Based on aggregated 13F filings for Q3 2020.